Potential Role of JAK Inhibitors in Atopic Dermatitis Treatment

Jamie L. McConaha, PharmD, NCTTP, BCACP, CDE, provides an overview of atopic dermatitis.

Peter Lio, MD, discusses patient factors to consider before deciding on a treatment strategy for atopic dermatitis.

Kristen Demundo, PharmD, addresses the safety and efficacy of some topical agents used as therapy options for atopic dermatitis.

Jamie L. McConaha, PharmD, NCTTP, BCACP, CDE, focuses on the safety and efficacy of systemic agents used to treat atopic dermatitis.

Shannon M. Rotolo, PharmD, BCPS, examines the role dupilimab plays as a disease-modifying therapy for the treatment of moderate-to-severe atopic dermatitis, and Peter Lio, MD, considers the unmet needs that exist within atopic dermatitis therapy.

A panel of experts discuss JAK inhibitors and their potential impact on the management of atopic dermatitis.

Kristen Demundo, PharmD, and Shannon M. Rotolo, PharmD, BCPS, review the important role pharmacists play in helping patients manage their atopic dermatitis condition and treatment.

Jamie L. McConaha, PharmD, NCTTP, BCACP, CDE, considers the benefit of over-the-counter options for battling atopic dermatitis, such as the topical products CeraVe and Eucerin.

Shannon M. Rotolo, PharmD, BCPS, discusses what prompts pharmacists to make physician referrals to patients with atopic dermatitis and offers some beneficial advice.